BDB555502

CD49d Mouse anti-Human, Unlabeled, Clone: 9F10, BD

Manufacturer: BD Biosciences

Select a Size

Pack Size SKU Availability Price
Each of 1 BDB555502-Each-of-1 In Stock ₹ 15,548.30

BDB555502 - Each of 1

₹ 15,548.30

In Stock

Quantity

1

Base Price: ₹ 15,548.30

GST (18%): ₹ 2,798.694

Total Price: ₹ 18,346.994

Antigen

CD49d

Classification

Monoclonal

Concentration

0.5mg/mL

Description

Integrin α4 chain; Integrin alpha 4; ITGA4; IA4; alpha 4 subunit of VLA-4

Host Species

Mouse

Quantity

0.1 mg

Research Discipline

Immunology

Target Species

Baboon, Bovine, Canine, Cynomolgus, Equine, Feline, Human, Rhesus Monkey, Sheep

Isotype

IgG1 κ

Applications

Flow Cytometry

Clone

9F10

Conjugate

Unconjugated

Formulation

Aqueous buffered solution containing ≤0.09% sodium azide.

Purification Method

Affinity Purified

Regulatory Status

RUO

Primary or Secondary

Primary

Content And Storage

Store undiluted at 4°C

Related Products

Img

BD Biosciences

BDB555752

--

Img

BD Biosciences

BDB555501

--

Img

BD Biosciences

BDB555396

--

Img

BD Biosciences

BDB555551

--

Img

BD Biosciences

BDB555442

--

Img

BD Biosciences

BDB555734

--

Img

BD Biosciences

BDB555593

--

Img

BD Biosciences

BDB555497

--

Description

  • Reaacts with the integrin α4 chain, which is expressed as a heterodimer with either of two β subunits, β1 (CD29) or β7
  • The α4β 1 integrin (VLA-4) is expressed on lymphocytes, monocytes, thymocytes, NK cells, and several B- and T-cell lines, and mediates binding to VCAM-1 (CD106) and the CS-1 region of fibronectin
  • The α4β7 integrin has a similar tissue distribution, except it is found on only a small subpopulation of thymocytes
  • Integrin α4β7 also binds fibronectin and VCAM-1, and has been shown in the mouse to preferentially bind the mucosal vascular addressin molecule, MAdCAM-1
  • This antibody is useful for studies of the expression and function of a4 chain-containing integrins
  • This antibody is routinely tested by flow cytometric analysis
  • Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.